Dr. Arkadiusz Surazynski is a habilitated doctor of pharmaceutical sciences and Head of the Department of Medicinal Chemistry at the Medical University of Białystok, Poland. His research focuses on molecular mechanisms of cancer progression, with particular emphasis on prolidase and PRODH or POX dependent regulation of apoptosis, autophagy, oxidative stress, and collagen metabolism. He completed scientific training at the National Cancer Institute (Frederick, USA) and has extensive experience in experimental oncology, cell signaling, and translational research. Dr. Surazynski has authored numerous peer-reviewed publications, patents, and interdisciplinary projects spanning oncology, inflammation, and skin biology.
CRDWC 2026
Poster Presentation